Evidence map›Paper›PMID 30061386›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm.

Evangelia Vamvaka, Gemma Farré, Luis M Molinos-Albert, Abbey Evans, Anna Canela-Xandri, Richard M Twyman, Jorge Carrillo, Raziel A Ordóñez, Robin J Shattock, Barry R O'Keefe and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Plant-based biopharmaceutical engineering.Nature reviews bioengineering · 2023
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. COVID-19 Crisis: How Can Plant Biotechnology Help?Plants (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 3 countries.

Evangelia VamvakaDepartment of Plant Production and Forestry Science, School of Agrifood and Forestry Science and Engineering, University of Lleida-Agrotecnio Center, 25198 Lleida, Spain.
Gemma FarréDepartment of Plant Production and Forestry Science, School of Agrifood and Forestry Science and Engineering, University of Lleida-Agrotecnio Center, 25198 Lleida, Spain.
Luis M Molinos-AlbertIrsiCaixa AIDS Research Institute, Institut de Recerca Germans Trias i Pujol, Germans Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.
Abbey EvansDepartment of Medicine, Imperial College London, W2 1PG London, United Kingdom.
Anna Canela-XandriDepartment of Plant Production and Forestry Science, School of Agrifood and Forestry Science and Engineering, University of Lleida-Agrotecnio Center, 25198 Lleida, Spain.
Richard M TwymanTRM Ltd, YO11 9FJ Scarborough, United Kingdom.ORCID 0000-0002-8764-3003
Jorge CarrilloIrsiCaixa AIDS Research Institute, Institut de Recerca Germans Trias i Pujol, Germans Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.ORCID 0000-0003-0221-5948
Raziel A OrdóñezDepartment of Plant Production and Forestry Science, School of Agrifood and Forestry Science and Engineering, University of Lleida-Agrotecnio Center, 25198 Lleida, Spain.
Robin J ShattockDepartment of Medicine, Imperial College London, W2 1PG London, United Kingdom.
Barry R O'KeefeMolecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702.
Bonaventura ClotetIrsiCaixa AIDS Research Institute, Institut de Recerca Germans Trias i Pujol, Germans Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.
Julian BlancoIrsiCaixa AIDS Research Institute, Institut de Recerca Germans Trias i Pujol, Germans Trias i Pujol University Hospital, 08916 Badalona, Barcelona, Spain.
Gurdev S KhushDepartment of Plant Sciences, University of California, Davis, CA 95616; gurdev@khush.org christou@pvcf.udl.es teresa.capell@pvcf.udl.cat.
Paul ChristouDepartment of Plant Production and Forestry Science, School of Agrifood and Forestry Science and Engineering, University of Lleida-Agrotecnio Center, 25198 Lleida, Spain; gurdev@khush.org christou@pvcf.udl.es teresa.capell@pvcf.udl.cat.
Teresa CapellDepartment of Plant Production and Forestry Science, School of Agrifood and Forestry Science and Engineering, University of Lleida-Agrotecnio Center, 25198 Lleida, Spain; gurdev@khush.org christou@pvcf.udl.es teresa.capell@pvcf.udl.cat.
Universitat de Lleida · ESImperial College London · GBIrsiCaixa · ESUniversitat de Vic - Universitat Central de Catalunya · ESInstitució Catalana de Recerca i Estudis Avançats · ESNational Institutes of Health · USUniversity of California, Davis · US

Funding

Isolation of bioactive proteins from natural product extractsZIABC011472 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OKEEFE, BARRY · 2012 to 2025
$7.8M
6 · The paper itself

Abstract

The transmission of HIV can be prevented by the application of neutralizing monoclonal antibodies and lectins. Traditional recombinant protein manufacturing platforms lack sufficient capacity and are too expensive for developing countries, which suffer the greatest disease burden. Plants offer an inexpensive and scalable alternative manufacturing platform that can produce multiple components in a single plant, which is important because multiple components are required to avoid the rapid emergence of HIV-1 strains resistant to single microbicides. Furthermore, crude extracts can be used directly for prophylaxis to avoid the massive costs of downstream processing and purification. We investigated whether rice could simultaneously produce three functional HIV-neutralizing proteins (the monoclonal antibody 2G12, and the lectins griffithsin and cyanovirin-N). Preliminary in vitro tests showed that the cocktail of three proteins bound to gp120 and achieved HIV-1 neutralization. Remarkably, when we mixed the components with crude extracts of wild-type rice endosperm, we observed enhanced binding to gp120 in vitro and synergistic neutralization when all three components were present. Extracts of transgenic plants expressing all three proteins also showed enhanced in vitro binding to gp120 and synergistic HIV-1 neutralization. Fractionation of the rice extracts suggested that the enhanced gp120 binding was dependent on rice proteins, primarily the globulin fraction. Therefore, the production of HIV-1 microbicides in rice may not only reduce costs compared to traditional platforms but may also provide functional benefits in terms of microbicidal potency.

Indexed as

Antibodies, MonoclonalAnti-HIV AgentsEndospermHIV AntibodiesOryzaPlants, Genetically ModifiedHIV-1HIV Envelope Protein gp120Antibodies, MonoclonalAnti-HIV Agentsgp120 protein, Human immunodeficiency virus 1HIV AntibodiesHIV Envelope Protein gp120gp120 bindingHIV combination microbicidesOryza sativaplant-made pharmaceuticalsrice globulins

Identifiers

PMID30061386
PMCPMC6099877
OpenAlexW2887607393

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.